Skip to content
10-Q

Quarterly Report

HUMAN GENOME SCIENCES INC

0001193125-12-182654

← back to feed
Filed
Apr 26, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Mar 31, 2012 199.07M sh
Stock Repurchased Q1 2012 · Mar 31, 2012 $283K
Stock Repurchased Q1 2012 · Mar 31, 2011 $1.04M
Capex Q1 2012 · Mar 31, 2012 $2.21M
Capex Q1 2012 · Mar 31, 2011 $2.4M
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$83.02M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$136.26M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $349.22M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $402.05M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $47.96M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $155.69M
Stockholders Equity Q1 2012 · Mar 31, 2012 $376.67M
Stockholders Equity Q1 2012 · Dec 31, 2011 $456.42M
Current Liabilities Q1 2012 · Mar 31, 2012 $312.55M
Current Liabilities Q1 2012 · Dec 31, 2011 $323.55M
Total Liabilities Q1 2012 · Mar 31, 2012 $951.5M
Total Liabilities Q1 2012 · Dec 31, 2011 $951.16M
Current Assets Q1 2012 · Mar 31, 2012 $615.69M
Current Assets Q1 2012 · Dec 31, 2011 $650.1M
Total Assets Q1 2012 · Mar 31, 2012 $1.33B
Total Assets Q1 2012 · Dec 31, 2011 $1.41B
Rd Expense Q1 2012 · Mar 31, 2012 $39.57M
Rd Expense Q1 2012 · Mar 31, 2011 $84.49M
Net Income Q1 2012 · Mar 31, 2012 −$93.5M
Net Income Q1 2012 · Mar 31, 2011 −$131M
Operating Income Q1 2012 · Mar 31, 2012 −$76.18M
Operating Income Q1 2012 · Mar 31, 2011 −$116M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $8.28M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $10M
Revenue Q1 2012 · Mar 31, 2012 $47.13M
Revenue Q1 2012 · Mar 31, 2011 $26.57M